Connection

Sui-Yuan Chang to Reverse Transcriptase Inhibitors

Back to Details
This is a "connection" page, showing publications Sui-Yuan Chang has written about Reverse Transcriptase Inhibitors.
Sui-Yuan Chang
Connection Strength
0.167
Reverse Transcriptase Inhibitors
  1. Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients. Int J Antimicrob Agents. 2019 Jul; 54(1):35-42.
    View in: PubMed
    Score: 0.167
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.